Continuous renal replacement therapy (CRRT) remains the dominant form of renal support among critically ill patients worldwide. Current clinical practice on CRRT prescription mostly relies on high quality studies suggesting no impact of CRRT dose on critically ill patients' outcomes. Recent clinical practice guidelines have been developed based on these studies recommending a static prescribed CRRT dose of 20-25 ml/kg/h. There is a rationale for renewed attention to CRRT prescription/practice based on the concept of dynamic solute control adapted to the changing clinical needs of critically ill patients. In response, Acute Disease Quality Initiative convened a 17th consensus meeting centered on re-evaluation of CRRT. This work group developed 4 themes focused specifically on CRRT dose prescription, delivery and solute control that were summarized in a series of consensus statements, along with the identification of critical knowledge gaps. CRRT dose prescription and delivery can be based on effluent flow rate. Delivered dose should be routinely monitored to ensure coherence with prescribed dose. CRRT dose should be dynamic, in recognition of between- and within-patient variation in targeted solute control or unintended solute clearance. Quality measures specific for monitoring delivered CRRT dose have been proposed that require further validation, prior to implementation, into the practice of guiding optimal CRRT dosage.

Keywords:
Continuous renal replacement therapy, Precision CRRT , Solute control, CRRT dose, Adequacy of CRRT, Acute kidney injury, Dose, Intensity, Outcome, Quality
1.
Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
2.
Neri M, Villa G, Garzotto F, Bagshaw SM, Bellomo R, Cerda J, Ferrari F, Guggia S, Joannidis M, Kellum JA, et al: Nomenclature for renal replacement therapy in acute kidney injury: basic principles. Crit Care 2016, in press.
3.
Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C; ADQI Workgroup: The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-1863.
4.
Kidney Disease: Improving global outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;2:1-138.
5.
Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM: Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008;19:1233-1238.
6.
RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, et al: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-1638.
7.
VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, et al: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.
8.
Ronco C, Kellum JA, Bellomo R, Mehta RL: Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013;182:1-4.
9.
Ricci Z, Salvatori G, Bonello M, Pisitkun T, Bolgan I, D'Amico G, Dan M, Piccinni P, Ronco C: In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care 2005;9:R266-R273.
10.
Huang Z, Letteri JJ, Clark WR, Ronco C, Gao D: Operational characteristics of continuous renal replacement modalities used for critically ill patients with acute kidney injury. Int J Artif Organs 2008;31:525-534.
11.
Ricci Z, Ronco C, Bachetoni A, D'Amico G, Rossi S, Alessandri E, Rocco M, Pietropaoli P: Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care 2006;10:R67.
12.
Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 2003;94:c94-c98.
13.
Yasuda H, Uchino S, Uji M, Ohnuma T, Namba Y, Katayama S, Kawarazaki H, Toki N, Takeda K, Izawa J, et al; Japanese Society for Physicians and Trainees in Intensive Care Clinical Trial Group: The lower limit of intensity to control uremia during continuous renal replacement therapy. Crit Care 2014;18:539.
14.
Rewa O, Mottes T, Bagshaw SM: Quality measures for acute kidney injury and continuous renal replacement therapy. Curr Opin Crit Care 2015;21:490-499.
15.
Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit ‘down-time' on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003;29:575-578.
16.
Murugan R, Wen X, Keener C, Pike F, Palevsky PM, Unruh M, Finkel K, Vijayan A, Elder M, Chen YF, et al; Biological Markers of Recovery for the Kidney (BioMaRK) Study Investigators: Associations between intensity of RRT, inflammatory mediators, and outcomes. Clin J Am Soc Nephrol 2015;10:926-933.
17.
Fall P, Szerlip HM: Continuous renal replacement therapy: cause and treatment of electrolyte complications. Semin Dial 2010;23:581-585.
18.
Morimatsu H, Uchino S, Bellomo R, Ronco C: Continuous renal replacement therapy: does technique influence electrolyte and bicarbonate control? Int J Artif Organs 2003;26:289-296.
19.
Sharma S, Brugnara C, Betensky RA, Waikar SS: Reductions in red blood cell 2,3-diphosphoglycerate concentration during continuous renal replacement therapy. Clin J Am Soc Nephrol 2015;10:74-79.
20.
Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ: Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011;26:3508-3514.
21.
Honore PM, De Waele E, Jacobs R, Mattens S, Rose T, Joannes-Boyau O, De Regt J, Verfaillie L, Van Gorp V, Boer W, et al: Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif 2013;35:279-284.
22.
Wooley JA, Btaiche IF, Good KL: Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 2005;20:176-191.
23.
Lewis SJ, Mueller BA: Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent. Semin Dial 2014;27:441-445.
24.
Lewis SJ, Mueller BA: Antibiotic dosing in patients with acute kidney injury: ‘enough but not too much'. J Intensive Care Med 2016;31:164-176.
25.
Ricci Z, Romagnoli S, Ronco C: Renal replacement therapy. F1000Res 2016;5:pii:F1000 Faculty Rev-103.
26.
Tolwani A: Continuous renal-replacement therapy for acute kidney injury. N Engl J Med 2012;367:2505-2514.
27.
Friedrich JO, Wald R, Bagshaw SM, Burns KE, Adhikari NK: Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care 2012;16:R146.
28.
Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-492.
29.
Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, De Waele E, van Gorp V, Boer W, Verfaillie L, Spapen HD: Newly designed CRRT membranes for sepsis and SIRS - a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J 2013;59:99-106.
30.
Maldonado Toral C, Dono L, Parra A, Ramos N, Albertos R, Papiol E, Perez M: Weight gain a risk factor for mortality in patients with acute kidney injury requiring continuous renal replacement therapy. Intensive Care Med Exp 2015;3(suppl 1):A466.
31.
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, et al: Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015;41:1411-1423.
32.
Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, Cruz D, Finn J, Hoste EE, Kashani K, et al; Acute Kidney Injury-6 Study Group: Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol 2015;41:81-88.
33.
Sharma A, Zaragoza JJ, Villa G, Ribeiro LC, Lu R, Sartori M, Faggiana E, de Cal M, Virzi GM, Corradi V, et al: Optimizing a kidney stress test to evaluate renal functional reserve. Clin Nephrol 2016;86:18-26.
34.
Naka T, Bellomo R, Morimatsu H, Rocktaschel J, Wan L, Gow P, Angus P: Acid-base balance in combined severe hepatic and renal failure: a quantitative analysis. Int J Artif Organs 2008;31:288-294.
35.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 2004;8:R204-R212.
36.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network: Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
37.
Ronco C, Bellomo R, Ricci Z: Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001;16(suppl 5):67-72.
38.
Wald R, McArthur E, Adhikari NK, Bagshaw SM, Burns KE, Garg AX, Harel Z, Kitchlu A, Mazer CD, Nash DM, et al: Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis 2015;65:870-877.
39.
Elseviers MM, Lins RL, Van der Niepen P, Hoste E, Malbrain ML, Damas P, Devriendt J; SHARF Investigators: Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care 2010;14:R221.
40.
Rewa O, Villeneuve PM, Eurich DT, Stelfox HT, Gibney RT, Hartling L, Featherstone R, Bagshaw SM: Quality indicators in continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review. Syst Rev 2015;4:102.
41.
Claure-Del Granado R, Macedo E, Chertow GM, Soroko S, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL: Toward the optimal dose metric in continuous renal replacement therapy. Int J Artif Organs 2012;35:413-424.
42.
Lyndon WD, Wille KM, Tolwani AJ: Solute clearance in CRRT: prescribed dose versus actual delivered dose. Nephrol Dial Transplant 2012;27:952-956.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.